STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more

Stat News5/14/2026 – 5/18/2026

Summary

No summary yet.

Share:XRedditLinkedIn

Advertisement

Cluster Activity

2
1
2
2026-05-142026-05-18

Lindy Score Breakdown (V4.2)

2d
Age
1
Sources
from cluster
53
Hours Since Seen
Final Score6/100
CategoryAntiLindy
StatusActive
Recency Multiplier47% (0.5^53/48)
Hero EligibleYes

Story Timeline

  1. 2026-05-14
  2. 2026-05-15
  3. 2026-05-18
    STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more (current)

Score BreakdownRisk 65

Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 2 day(s) old - still early

Stories gain Lindy status through source reputation, network consensus, and time survival.

Same Story from 5 sources

Breaking Similar stories

Anti-Lindy Similar stories